UNLOCKD Inc., a publicly traded holding company building a diversified consumer health and wellness platform, has signed a binding Letter of Intent to acquire 100% of Ancient Extracts Ltd, which operates as Ancient Extracts UK, a British direct-to-consumer functional wellness business. The proposed transaction, announced by parent company BitFrontier Capital Holdings, Inc. (OTCID: BFCH), would bring Ancient Extracts UK together with UNLOCKD's existing Ancient Extracts USA business, establishing a presence in both the United States and United Kingdom.
Ancient Extracts UK currently reports approximately $77,000 in monthly revenue, representing an annualized revenue run rate of approximately $920,000 based on preliminary management-provided financial information. With revenue continuing to grow organically, the business is approaching the $1 million annualized revenue milestone, which management views as an early milestone in a substantially larger growth opportunity. The company has signaled that it intends to outline a vision for building Ancient Extracts into a business capable of generating $100 million or more in annual revenue, supported by the scale achieved by comparable wellness brands and the broader addressable market.
The acquisition matters because it would expand UNLOCKD's revenue-generating operations through a structured equity transaction with defined financing, audit, and closing requirements. Under the binding LOI dated October 26, 2026, UNLOCKD proposes to acquire 100% of Ancient Extracts UK for $1.8 million in restricted BFCH common stock, with additional founder management equity, performance-based incentives, financing-linked cash consideration, and continuing employment arrangements contemplated under the agreement. Closing is conditioned upon BFCH raising at least $500,000 in qualifying financing, completion of an acceptable financial audit of Ancient Extracts UK, satisfactory due diligence, required approvals, and execution of definitive agreements. The LOI includes a 120-day exclusivity period.
John P. Gorst, Chief Executive Officer of UNLOCKD, said the structure is designed to align the transaction with execution. "The proposed acquisition provides for BFCH to acquire 100% of Ancient Extracts UK primarily through restricted common stock, with additional consideration tied to management participation, performance, and financing," Gorst said. "Just as importantly, closing is conditioned upon qualifying capital, completion of an acceptable financial audit, satisfactory due diligence, and definitive agreements. We believe this structure establishes a clear framework for advancing the transaction while safeguarding the interests of BFCH and its shareholders."
The company's portfolio includes Ancient Extracts USA, a revenue-generating functional wellness business with an expanding product portfolio and distribution strategy; EVERMIND, a functional wellness platform with proprietary formulations and intellectual property; and 1ENERGY, a developed functional energy-shot brand. Ancient Extracts UK offers mushroom-based products, specialty coffee formulations, Himalayan shilajit, ceremonial matcha, and other wellness products through an established direct-to-consumer e-commerce business with recurring subscription customers and a diversified product portfolio. More information about the company is available at https://unlockdinc.com/, and details about the acquisition target can be found at https://www.ancientextracts.co.uk/.
The acquisition remains subject to its closing conditions, and there can be no assurance that the proposed transaction will be completed. UNLOCKD intends to advance the required financing, financial audit, due diligence, and definitive transaction documentation in accordance with the terms of the LOI. The company expects to provide additional details regarding Ancient Extracts UK's operating economics, gross margins, customer retention, subscription revenue, digital marketing performance, and the broader commercial opportunity for the combined Ancient Extracts businesses in a subsequent announcement expected November 5, 2026. The news was distributed through NEWMEDIAWIRE.


